A Phase 2 Study of the IDO Inhibitor Epacadostat Versus Tamoxifen for Subjects With Biochemical-recurrent-only EOC, PPC or FTC Following Complete Remission With First-line Chemotherapy
Clinical trial NCT01685255 · TERMINATED
Trial details
- NCT number
- NCT01685255
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-10-23
- Enrollment
- 83
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.